Epididymo-orchitis

• The most common cause in people < 35 years is Chlamydia trachomatis and occasionally Neisseria gonorrhoeae.
• In sexually active people of ANY age, Chlamydia trachomatis and Neisseria gonorrhoeae remain the most likely cause of epididymo-orchitis. For people who have insertive anal sex, and people who have had recent instrumentation, there is a higher likelihood of enteric pathogens (g. Escherichia coli and Proteus spp).
• Rarer causes include paramyxovirus (mumps), amiodarone use, tuberculosis, brucellosis, Candida spp, cryptococcosis, and Behçet syndrome.
• Mycoplasma genitalium may be a cause although the evidence is limited.

• Non-STI causes for epididymo-orchitis are possible in the presence of a urinary tract infection or prostatitis.

NAAT – Nucleic acid amplification test

Specimen collection guidance

Clinician collected | Self-collection

Investigations

• Physical examination to determine exact site and nature of swelling and tenderness
• If present, collect sample of urethral discharge for microscopy, culture and sensitivity (MC&S)
• Collect first pass urine and mid stream urine specimens
• If diagnosis uncertain, Doppler ultrasonography may help exclude testicular infarction, torsion or tumour.

Special considerations

• If diagnosis remains uncertain and pain is severe, refer for urgent surgical assessment. Torsion can result in the loss of the testis within hours. In these cases, it is usually best to refer without ultrasound to avoid delay.

Treat sexually active men with epididymo-orchitis presumptively for gonorrhoea and chlamydia.

Treatment advice

• For men who engage in insertive anal sex, treat empirically as above, however if response is poor, alternative treatment may be required to treat enteric organisms. Seek specialist advice.
• Modify therapy based on the results of investigations and clinical response. In severe cases, treatment may need to be continued for up to 3 weeks. Seek specialist advice.
• Bed rest, scrotal support and analgesia are commonly required. Complete resolution of the swelling may take several weeks, but a substantial response should occur in 4-5 days.

Other immediate management

• Advise no sexual contact for 7 days after treatment is commenced, or until the course is completed and symptoms resolved, whichever is later.
• Advise no sex with partners from the last 6 months until the partners have been tested and treated if necessary.
• Comprehensive STI testing may be appropriate, depending on the patient’s sexual history.
• Contact tracing.
• Provide patient with factsheet.

• If STI-related, all sexual partners from the past 6 months should be tested and treated
• If urinary tract infection, contact tracing is not required

See Australasian Contact Tracing Manual – Epididymitis for more information.

Follow-up at 4-5 days provides an opportunity to:

• Assess treatment response and reassess in light of the test results, including antibiotic sensitivities
• If STI-related, confirm that sexual partners have been properly managed. Offer more contact tracing support if needed
• Provide further sexual health education and prevention counselling
• Men with chlamydia and gonorrhoea should be retested for re-infection after 3 months
• Confirmed urinary tract infections in men often require further investigation or urological referral.

Consider testing for other STIs, if not undertaken at first presentation, or retesting post the window period.

Test of cure is not recommended.

• If STI-related, 100% of regular partners are tested and treated.